MrTicker
$IGC Has yet to run .. IGC Pharma's Alzheimer's Agitation Drug Candidate Now Patented in the U.S., Canada, and Mexico as Phase 2 Readout NearsCanada grants patent on IGC-AD1, an investigational oral therapy for agitation in Alzheimer's disease. Agitation is one of the hardest symptoms for families to manage.
ACCESS NEWSWIRE 9:18 AM ET 11/5/2026
$SLS loading opportunity..
3
